|
Volumn 117, Issue 6, 2001, Pages 1363-1368
|
Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62e expression in an NF-κB-Dependent manner
|
Author keywords
CD54; Endothelial cells; Fumaric acid esters; Methylhydrogenfumarate; Psoriasis
|
Indexed keywords
DIMETHYLFUMARATE;
FUMARIC ACID DERIVATIVE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INTERCELLULAR ADHESION MOLECULE 1;
METHYLHYDROGENFUMARATE;
PADGEM PROTEIN;
PROTEIN;
PROTEIN AP 1;
TUMOR NECROSIS FACTOR;
UNCLASSIFIED DRUG;
ANTIGEN EXPRESSION;
ARTICLE;
CASE REPORT;
CLINICAL TRIAL;
CONCENTRATION (PARAMETERS);
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
ENDOTHELIUM CELL;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
KINETICS;
MICROVASCULATURE;
MOLECULAR DYNAMICS;
PRIORITY JOURNAL;
PSORIASIS;
SKIN DEFECT;
TIME;
UMBILICAL VEIN;
|
EID: 0035675207
PISSN: 0022202X
EISSN: None
Source Type: Journal
DOI: 10.1046/j.0022-202x.2001.01576.x Document Type: Article |
Times cited : (62)
|
References (27)
|